High Tide Inc.
NASDAQ:HITIMedical - Pharmaceuticals
-$0.05 today
- Market cap
- $211.27M
- Beta
- 0.57
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$0.50
Volume 0.32M
Average 0.61M
HITI Interest Expense
Cost of servicing the company's debt during the period.
High Tide Inc.NASDAQ: HITI
Interest Expense · Q2 FY2026 · quarter ended Apr 2026
Interest expense growth accelerates
Q2 FY2026 interest expense of CA$5.15M rose 51.6% year over year, ahead of the +10.1% change in trailing-twelve-month interest expense. Sequentially, it rose 4.6% from the prior quarter. Over 3 fiscal years it compounded at +10.4% a year.
Context
- Interest expense amounted to 2.3% of revenue in FY2025, down 0.2 pp from a year earlier.
- Interest expense increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +51.6% holds above the trailing-twelve-month pace of +10.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
CAD · from the income statement
- Latest · FY2025
- 13.38M CAD
- Year-over-year change
- +4.6%
- 4-year CAGR
- +6.9%
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-10-31 | 13.38M | +4.6% |
| FY2024 | 2024-10-31 | 12.79M | +10.0% |
| FY2023 | 2023-10-31 | 11.64M | +17.0% |
| FY2022 | 2022-10-31 | 9.95M | -2.9% |
| FY2021 | 2021-10-31 | 10.24M | — |
Interest Expense vs competitors
How HITI compares with its peers on the latest reported figures
- Peers report in different currencies, so interest expense is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +10.1% is the highest of 5, against a peer median of -44.9%.
- Interest expense amounts to 2.3% of revenue for HITI, versus a peer median of 3.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$41.67M CAD | -44.1% | -32.9% | 13.4% | |
| LTM Mar 2026 | $37.61M USD | +7.6% | -0.9% | 14.4% | |
| LTM Apr 2026 | CA$15.52M CAD | +10.1% | +10.4% | 2.3% | |
| LTM Mar 2026 | CA$5.29M CAD | -45.7% | -33.5% | 3.3% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 CAD | -100.0% | — | 0.0% | |
| Peer median (excluding HITI) | — | -44.9% | -32.9% | 3.3% | |
Competitors are the stored peer set for HITI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Oct 2021 | FY2022 Oct 2022 | FY2023 Oct 2023 | FY2024 Oct 2024 | FY2025 Oct 2025 |
|---|---|---|---|---|---|
| Revenue | 181.12M | 356.85M | 487.67M | 522.31M | 593.99M |
| Cost of Revenue | 117.14M | 255.9M | 356.36M | 379.8M | 440.46M |
| Gross Profit | 63.98M | 100.95M | 131.31M | 142.5M | 153.53M |
| Gross Margin | 35.3% | 28.3% | 26.9% | 27.3% | 25.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 54.27M | 90.9M | 101.21M | 101.79M | 113.78M |
| Operating Expenses | 82.66M | 173.26M | 172.74M | 137.5M | 167.98M |
| Depreciation & Amortization | 23.57M | 30.17M | 32.76M | 25.39M | 24.31M |
| EBITDA | (1.96M) | (33.65M) | (4.2M) | 33.78M | (13.74M) |
| EBITDA Margin | -1.1% | -9.4% | -0.9% | 6.5% | -2.3% |
| Operating Income | (18.67M) | (72.31M) | (41.43M) | 5M | (14.45M) |
| Operating Margin | -10.3% | -20.3% | -8.5% | 1.0% | -2.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 10.24M | 9.95M | 11.64M | 12.79M | 13.38M |
| Other Income / Expenses | (17.09M) | (1.45M) | (7.17M) | (9.41M) | (36.98M) |
| Income Before Tax | (35.77M) | (73.76M) | (48.6M) | (4.4M) | (51.43M) |
| Pre-Tax Margin | -19.7% | -20.7% | -10.0% | -0.8% | -8.7% |
| Income Tax Expense | (730K) | (2.92M) | (7.64M) | (593K) | (25K) |
| Net Income | (34.36M) | (71.76M) | (39.31M) | (4.34M) | (50.75M) |
| Net Margin | -19.0% | -20.1% | -8.1% | -0.8% | -8.5% |
| EPS (Basic) | (0.83) | (1.13) | (0.53) | (0.05) | (0.62) |
| EPS (Diluted) | (0.83) | (1.13) | (0.53) | (0.05) | (0.62) |
| Weighted Avg Shares | 42.43M | 62.78M | 74.33M | 79.56M | 82.18M |
| Weighted Avg Shares (Diluted) | 42.43M | 62.78M | 74.33M | 79.56M | 82.18M |
High Tide Inc.
NASDAQ:HITI
Intrinsic Alpha fair value
Locked
Current Price
$2.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.